Dr Sheau Wen Lok
Honorary (Fellow)
Department of Medical Biology (WEHI)
20 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
Trodelvy use in advanced triple negative breast cancer in Australia (TRACIE): Study design and interim analysis.
DOI: 10.1200/JCO.2025.43.16_suppl.e131302024
Journal article
Medicine Access Programmes: what do patients think – a patient-reported outcome study on ribociclib in metastatic breast cancer in Australia
DOI: 10.1111/imj.165362023
Journal article
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 /HR metastatic breast cancer
DOI: 10.1007/s10549-022-06856-12023
Journal article
Pertuzumab study in the neoadjuvant setting for HER2-positive nonmetastatic breast cancer in Australia (PeRSIA)
DOI: 10.1002/ijc.342452022
Journal article
Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer
DOI: 10.1016/j.clbc.2022.08.0112022
Conference Proceedings
Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study
DOI: 10.1016/j.clbc.2022.07.0052019
Journal article
A phase Ib dose-escalation and expansion study of the BCL2 inhibitor venetoclax combined with tamoxifen in ER and BCL2– positive metastatic breast cancer
DOI: 10.1158/2159-8290.CD-18-1151
RECENT SCHOLARLY WORKS
2022
Journal article
Uptake of bone-modifying agents in patients with HER2 metastatic breast cancer with bone metastases – prospective data from a multi-site Australian registry
DOI: 10.1111/imj.153762022
Journal article
Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support Activities
DOI: 10.3390/cancers141741312021
Journal article
Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease setting
DOI: 10.1002/ijc.335682021
Journal article
Stage dependent recurrence patterns and post-recurrence outcomes in non-metastatic colon cancer
DOI: 10.1080/0284186X.2021.1943519